Poseida Therapeutics, Inc. (PSTX) Tops Q1 EPS by 16c
Tweet
Share
E-mailGet Alerts PSTX Hot Sheet
Price: $9.50 --0%
Financial Fact:
Research and development: 168.56K
Today's EPS Names:
CRWS, MEI, PODC, More
Financial Fact:
Research and development: 168.56K
Today's EPS Names:
CRWS, MEI, PODC, More
Join SI Premium – FREE
Poseida Therapeutics, Inc. (NASDAQ: PSTX) reported Q1 EPS of ($0.45), $0.16 better than the analyst estimate of ($0.61). Revenue for the quarter came in at $10.34 million versus the consensus estimate of $1.57 million.
For earnings history and earnings-related data on Poseida Therapeutics, Inc. (PSTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
- BofA lists top 5 themes driving next $1tn in incremental semi sales
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
